Preclinical evidence and potential mechanisms of tanshinone ⅡA on cognitive function in animal models of Alzheimer’s disease: a systematic review and meta-analysis
BackgroundTanshinone ⅡA (Tan ⅡA) is a monomer extracted from Salvia miltiorrhiza Bunge. Animal studies have demonstrated its potential in providing cognitive protection in Alzheimer’s disease (AD), but the overall effects remain inconclusive, and its multiple mechanisms have not been systematically...
Saved in:
| Main Authors: | Yuanhang Rong, Qinqing Li, Yuzhong Du, Wenting Wang, Wenna Su, Junlong Zhang, Wenbin He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1603861/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of tanshinones on cognitive impairments in animal models of Alzheimer’s disease: a systematic review and meta-analysis
by: Shuwei Wang, et al.
Published: (2025-02-01) -
Therapeutic Potential of Tanshinones in Osteolytic Diseases: From Molecular and Cellular Pathways to Preclinical Models
by: Rafael Scaf de Molon
Published: (2025-07-01) -
Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation
by: Wang Q, et al.
Published: (2025-01-01) -
Tanshinone IIA induces oxidative stress in trophoblast cells and enhances copper dependent death
by: Juemeng Du, et al.
Published: (2025-07-01) -
Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases
by: Lanxiang Du, et al.
Published: (2025-07-01)